# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-25-123682
Filing Date
2025-05-21
Accepted
2025-05-21 08:47:38
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-05-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | d88153dars.pdf | ARS | 1013446
| Complete submission text file | 0001193125-25-123682.txt |  | 1397411

Mailing Address 2617 BISSONNET ST SUITE 233 HOUSTON TX 77005
Business Address 2617 BISSONNET ST SUITE 233 HOUSTON TX 77005 (346) 355-4099
Alaunos Therapeutics, Inc. (Filer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-33038 | Film No.: 25970998
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)